133P The efficacy and safety of KN046 combined with axitinib for previously untreated and checkpoint inhibitor treated advanced non-small cell lung cancer: A single-arm, open-label, multicenter phase II clinical trial

作者：Li Zhang, Yanjiao Zhao, Xue Meng, Yunchao Huang, W. Fang, Yadi Yang, Jie Shi, B. Liu, Wenyi Zhuang, Ying Fang, Heng Zhao, Xingqiong Meng, An Liu, Li Zhang, Jian Fang, Jing Zhang, Jianwei Cheng · 发表于：Immuno-Oncology Technology · 年份：2024 · DOI：10.1016/j.iotech.2024.100762 · 被引用次数：3 · 研究领域：Lung Cancer Treatments and Mutations、Colorectal Cancer Treatments and Studies、Lung Cancer Research Studies